Growth Metrics

Omeros (OMER) Cash from Operations Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 60.84%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 85.14%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -15.72%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 74.39%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 3.23%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 158.60%
10 Omeros 772.03 Mn 636.71 Mn 9.31 Mn 59.53%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 59.53%
Dec 31, 2025 -37.48%
Sep 30, 2025 42.44%
Jun 30, 2025 52.25%
Mar 31, 2025 14.21%
Dec 31, 2024 16.78%
Sep 30, 2024 1.80%
Jun 30, 2024 -42.19%
Mar 31, 2024 -123.94%
Dec 31, 2023 -37.20%
Sep 30, 2023 -23.48%
Jun 30, 2023 -66.12%
Mar 31, 2023 1,248.81%
Dec 31, 2022 -39.35%
Sep 30, 2022 -11.74%
Jun 30, 2022 29.44%
Mar 31, 2022 62.26%
Dec 31, 2021 1.04%
Sep 30, 2021 32.28%
Jun 30, 2021 26.61%
Mar 31, 2021 -340.37%
Dec 31, 2020 20.02%
Sep 30, 2020 -364.52%
Jun 30, 2020 -126.64%
Mar 31, 2020 29.40%
Dec 31, 2019 6.66%
Sep 30, 2019 79.60%
Jun 30, 2019 46.33%
Mar 31, 2019 -14.62%
Dec 31, 2018 -491.01%
Sep 30, 2018 -229.41%
Jun 30, 2018 -278.85%
Mar 31, 2018 11.07%
Dec 31, 2017 61.59%
Sep 30, 2017 0.21%
Jun 30, 2017 36.23%
Mar 31, 2017 23.61%
Dec 31, 2016 34.56%
Sep 30, 2016 23.10%
Jun 30, 2016 22.67%
Mar 31, 2016 4.85%
Dec 31, 2015 -5.79%
Sep 30, 2015 8.49%
Jun 30, 2015 -8.34%
Mar 31, 2015 -56.89%
Dec 31, 2014 -5,201.01%
Sep 30, 2014 -44.43%
Jun 30, 2014 -62.59%
Mar 31, 2014 -24.21%
Dec 31, 2013 97.68%
Sep 30, 2013 -49.14%
Jun 30, 2013 -6.00%
Mar 31, 2013 -62.91%
Dec 31, 2012 -73.67%
Sep 30, 2012 -80.20%
Jun 30, 2012 -40.09%
Mar 31, 2012 30.10%
Dec 31, 2011 -211.16%
Sep 30, 2011 30.37%